Per thor Straten
1994 …2020

Research activity per year

Network

Inge Marie Svane

Person: VIP

Manja Idorn

  • University of Copenhagen
  • Kobenhavns Universitet

External person

Eva Ellebaek

  • University of Copenhagen

External person

Tina Seremet

  • University of Copenhagen

External person

Marco Donia

  • University of Copenhagen

External person

Anne Rahbech

  • University of Copenhagen

External person

Jordi Rodon

  • Autonomous University of Barcelona
  • University of Texas MD Anderson Cancer Center

External person

Amalie Kai Bentzen

  • Technical University of Denmark

External person

Hans-Georg Rammensee

  • University of Tübingen
  • German Cancer Research Center

External person

Francisco Martínez-Ricarte

  • Autonomous University of Barcelona

External person

Sofie Ramskov

  • Technical University of Denmark

External person

Evelina Martinenaite

  • University of Copenhagen
  • Copenhagen University Hospital, Koege
  • IO Biotech ApS

External person

Norbert Hilf

  • Immatics Biotechnologies GmbH

External person

Bracha Shraibman

  • Technion-Israel Institute of Technology

External person

Trine Zeeberg Iversen

  • University of Copenhagen

External person

Sabrina Kuttruff-Coqui

  • Immatics Biotechnologies GmbH

External person

Berta Ponsati

  • BCN Peptides

External person

Sebastian Kreiter

  • BioNTech Ag
  • working group Cancer Immunoguiding Program

External person

Jon Amund Kyte

  • University of Oslo

External person

David Schrama

  • Medical University of Graz
  • University of Würzburg

External person

Paolo A Ascierto

  • IRCCS Istituto nazionale tumori Fondazione Giovanni Pascale - Napoli

External person

Ghazaleh Tabatabai

  • University of Tübingen
  • German Cancer Research Center

External person

Sjoerd H. van der Burg

  • working group Cancer Immunoguiding Program
  • Leiden University

External person

Katrin Frenzel

  • BioNTech Ag
  • Neuruppin Bonn

External person

Pierre Yves Dietrich

  • University of Geneva

External person

Judith R. Kroep

  • Leiden University

External person

Valerie Dutoit

  • University of Geneva

External person

Juan Sahuquillo

  • Autonomous University of Barcelona

External person

Troels Holz Borch

  • University of Copenhagen
  • Kobenhavns Universitet

External person

Henrik Schmidt

  • University of Southern Denmark
  • Aarhus University

External person

Cathrin Ritter

  • University of Duisburg-Essen
  • German Cancer Consortium (DKTK)
  • German Cancer Research Center

External person

Andreas von Deimling

  • Heidelberg University 
  • German Cancer Research Center

External person

John C. Castle

  • BioNTech Ag
  • Agenus

External person

Cedrik M. Britten

  • BioNTech Ag
  • working group Cancer Immunoguiding Program
  • GlaxoSmithKline

External person

Michael Platten

  • Heidelberg University 
  • German Cancer Research Center

External person

Hideho Okada

  • University of California at San Francisco
  • Parker Institute for Cancer Immunotherapy

External person

Ugur Sahin

  • BioNTech Ag

External person

Wolfgang Wick

  • Heidelberg University 
  • German Cancer Research Center

External person

Arie Admon

  • Technion-Israel Institute of Technology

External person

Colette Song

  • Immatics Biotechnologies GmbH

External person

Marlies J.W. Peeters

  • University of Copenhagen

External person

Christian H. Ottensmeier

  • University of Southampton

External person

Christian Blank

  • Netherlands Cancer Institute

External person

Pavel Gromov

  • Danish Cancer Society
  • Danish Ctr. Translational B. C. R.
  • Danish Centre for Translational Breast Cancer Research

External person

Katja Harbst

  • Lund University

External person

Denis Sasseville

  • McGill University

External person

Nina Pawlowski

  • Immatics Biotechnologies GmbH

External person

Caroline H Riley

  • University of Copenhagen

External person

Jörg Ludwig

  • Immatics Biotechnologies GmbH

External person

Stefan Stevanović

  • University of Tübingen
  • German Cancer Research Center

External person

Pieter Spee

  • PS Pharmaconsult

External person

Claudia Wagner

  • Immatics Biotechnologies GmbH

External person

Anneline Nansen

  • Novo Nordisk A/S (Biz)
  • Zealand Pharma A/S (Biz)

External person

Franziska Hoffgaard

  • Immatics Biotechnologies GmbH

External person

Monika Stieglbauer

  • University of Tübingen
  • working group Cancer Immunoguiding Program

External person

Mattias F Lindberg

  • University of Gothenburg

External person

Linda Cairns

  • IRCCS Istituto Europeo di Oncologia - Milano

External person

Andrea Anichini

  • IRCCS Fondazione Istituto Nazionale per lo studio e la cura dei tumori - Milano

External person

Sandra Heesch

  • BioNTech Ag

External person

Vibeke Mindahl Rafa

  • Technical University of Denmark

External person

Tim Fugmann

  • Philochem AG
  • Max Delbrück Center for Molecular Medicine in the Helmholtz Association

External person

Regina Mendrzyk

  • Immatics Biotechnologies GmbH

External person

Carsten Reinhardt

  • Immatics Biotechnologies GmbH

External person

Nadia Viborg

  • Technical University of Denmark

External person

Nigel P Mongan

  • Weill Cornell Medicine
  • University of Nottingham

External person

Martin Lauss

  • Lund University

External person

Ana Micaela Carnaz Simoes

  • University of Copenhagen

External person

Lauge Kellermann

  • University of Copenhagen

External person

Jonas A Nilsson

  • University of Gothenburg

External person

Toni Weinschenk

  • Immatics Biotechnologies GmbH

External person

Denis Migliorini

  • University of Geneva

External person

Harpreet Singh-Jasuja

  • Immatics Biotechnologies GmbH

External person

Jens Fritsche

  • Immatics Biotechnologies GmbH

External person

Henrik Ipsen

  • ALK-Abelló

External person

Per Kongsted

  • University of Copenhagen

External person

Irina Gromova

  • Danish Cancer Society
  • Danish Ctr. Translational B. C. R.
  • Danish Centre for Translational Breast Cancer Research

External person

Sonja Dorner

  • Immatics Biotechnologies GmbH

External person

Alexander Ulges

  • Immatics Biotechnologies GmbH

External person

Göran Jönsson

  • Lund University

External person

Lone Duval

  • Aarhus University

External person

Gitte Holmen Olofsson

  • University of Copenhagen

External person

Ahmad Awada

  • Université libre de Bruxelles

External person

Arbel D. Tadmor

  • Johannes Gutenberg University Mainz

External person

Hans Carl Hasselbalch

  • Zealand University Hospital, Køge

External person

Julio E. Celis

  • Danish Cancer Society
  • Danish Ctr. Translational B. C. R.
  • Danish Centre for Translational Breast Cancer Research

External person

Jenny L. Persson

  • Umeå University
  • Lund University

External person

Katharina Kiesel

  • Immatics Biotechnologies GmbH

External person

Ivan V Litvinov

  • McGill University
  • University of Ottawa

External person

Sascha Ott

  • Uppsala University

External person

David Capper

  • Heidelberg University 
  • German Cancer Research Center
  • Charité – Universitätsmedizin Berlin

External person

Valesca Bukur

  • BioNTech Ag

External person

Katy McCann

  • University of Southampton

External person

Lukas Bunse

  • Heidelberg University 
  • German Cancer Research Center

External person

Eugene Lukanidin

  • Kræftens Bekæmpelse

External person

Marco Skardelly

  • University of Tübingen

External person

Selma Ugurel-Becker

  • University of Duisburg-Essen

External person

Mariusz Wasik

  • University of Pennsylvania

External person

Jeurgen C. Becker

  • University of Duisburg-Essen

External person

Nicolle Rekers

  • Maastricht University

External person

Miriam Meyer

  • Immatics Biotechnologies GmbH

External person

Elisa Rusch

  • University of Tübingen
  • working group Cancer Immunoguiding Program

External person

Martin Löwer

  • BioNTech Ag

External person

Lluis M Mir

  • Université Paris-Saclay

External person

Shamaila Munir Ahmad

  • University of Copenhagen
  • Copenhagen University Hospital, Koege

External person

Jens Brimnes

  • Statens Serum Institut

External person

Sandrine Aspeslagh

  • Université Paris-Sud

External person

Sunil Kumar Saini

  • Danmarks Tekniske Universitet

External person

Gitte Holmen Olofsson

  • University of Copenhagen

External person

Caroline Hasselbalch Riley

  • University of Copenhagen

External person

Oliver Schoor

  • Immatics Biotechnologies GmbH

External person

Theo Sturm

  • Philochem AG

External person

Edward Green

  • German Cancer Research Center
  • Heidelberg University 

External person

Cécile Gouttefangeas

  • University of Tübingen
  • German Cancer Research Center
  • working group Cancer Immunoguiding Program

External person

Per Thor Straten

  • University of Copenhagen

External person

Christine Dethlefsen

  • Copenhagen University Hospital, Koege

External person

Sergei B Koralov

  • New York University

External person

Bernhard Rössler

  • Immatics Biotechnologies GmbH

External person

Teresa Cabezon

  • Danish Ctr. Translational B. C. R.
  • Danish Cancer Society
  • Danish Centre for Translational Breast Cancer Research

External person

Dorte Kinggaard Holm

  • Danish Ctr. Translational B. C. R.
  • Copenhagen University Hospital, Koege
  • University of Southern Denmark

External person

Rikke Lyngaa

  • University of Copenhagen

External person

Aron Charles Eklund

  • Center for Biological Sequence Analysis, Technical University of Denmark
  • Danmarks Tekniske Universitet

External person

Jordi Piró

  • BCN Peptides

External person

Donata Dulkeviciute

  • University of Copenhagen

External person

Marij J.P. Welters

  • working group Cancer Immunoguiding Program
  • Leiden University

External person

Elisabeth D Galsgaard

  • Novo Nordisk A/S (Biz)

External person

Arianna Draghi

  • Kobenhavns Universitet
  • University of Copenhagen

External person

Dominik Maurer

  • Immatics Biotechnologies GmbH

External person